Germany tightens law on stem cell treatments

BMJ 2009; 339 doi: http://dx.doi.org/10.1136/bmj.b2967 (Published 28 July 2009)
Cite this as: BMJ 2009;339:b2967

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Ned Stafford
  1. 1Hamburg

    Treatments in Germany involving adult stem cells will be more closely regulated after revision of Germany’s medical products law received final approval by the Bundesrat, the upper house of parliament.

    The Bundesrat approved the revisions on 10 July, just over two weeks after the German Society for Neurology and the German Parkinson Society issued a joint statement warning that patients with Parkinson’s disease should not undergo treatments involving bone marrow stem cells. Such treatments are being offered around the world, including at the XCell-Center in Cologne, the societies said in the statement on 23 June.

    The XCell-Center began operating in Cologne in January 2007, since when “more than 1600 patients have safely undergone our various stem cell treatments,” the centre’s website states.

    The website (www.xcell-center.com), available in 10 languages, gives a detailed overview …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL